Matches in SemOpenAlex for { <https://semopenalex.org/work/W3106348194> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W3106348194 abstract "Background: Studies have shown that nonvalvular atrial fibrillation (NVAF) patients who discontinue direct oral anticoagulants (DOAC) are at higher risk of complications, such as stroke. This analysis compared the risk of non-persistence of OACs among NVAF patients. Methods: Adult NVAF patients who initiated apixaban, dabigatran, rivaroxaban, or warfarin were identified using 01JAN2013-31MAR2019 data from the IQVIA commercial claims database. Non-persistence was defined as discontinuation (no evidence of index OAC use for 60 days from the last days’ of supply) or switch to another OAC. Kaplan-Meier (KM) curves were generated to illustrate time-to-non-persistence along with cumulative incidences of non-persistence. Adjusted cox proportional hazards models, including time-varying covariates (e.g., major bleeding, stroke), were used to evaluate non-persistence risk. Results: A total of 32,103 apixaban, 5,906 dabigatran, 29,385 rivaroxaban, and 21,420 warfarin patients were included; mean age: 63. Apixaban was associated with a lower risk of non-persistence compared to dabigatran (hazard ratio [HR]: 0.54; 95% confidence interval [CI]: 0.52-0.56), rivaroxaban (HR: 0.79; 95% CI: 0.78-0.81), and warfarin (HR: 0.66; 95% CI: 0.65-0.68). Dabigatran was associated with a higher risk of non-persistence compared to warfarin (HR: 1.23; 95% CI: 1.19-1.28) and rivaroxaban (HR: 1.47; 95% CI: 1.42-1.52), and rivaroxaban was associated with a lower risk compared to warfarin (HR: 0.84; 95% CI: 0.82-0.86). KM curves and cumulative incidences are presented below (Figure). Conclusions: In this group of NVAF patients, apixaban was associated with a significantly lower risk of non-persistence compared to dabigatran, rivaroxaban, and warfarin. Rivaroxaban was associated with a lower risk of non-persistence compared to warfarin and dabigatran. Such differences are critical as persistence with OACs is essential to prevent thromboembolic complications." @default.
- W3106348194 created "2020-11-23" @default.
- W3106348194 creator A5013717649 @default.
- W3106348194 creator A5017511355 @default.
- W3106348194 creator A5020043337 @default.
- W3106348194 creator A5045452931 @default.
- W3106348194 creator A5049704567 @default.
- W3106348194 creator A5081809233 @default.
- W3106348194 creator A5087610563 @default.
- W3106348194 creator A5089946954 @default.
- W3106348194 date "2020-11-17" @default.
- W3106348194 modified "2023-10-18" @default.
- W3106348194 title "Abstract 14354: Persistence to Oral Anticoagulation Treatment in Non-valvular Atrial Fibrillation Patients in the United States" @default.
- W3106348194 doi "https://doi.org/10.1161/circ.142.suppl_3.14354" @default.
- W3106348194 hasPublicationYear "2020" @default.
- W3106348194 type Work @default.
- W3106348194 sameAs 3106348194 @default.
- W3106348194 citedByCount "0" @default.
- W3106348194 crossrefType "journal-article" @default.
- W3106348194 hasAuthorship W3106348194A5013717649 @default.
- W3106348194 hasAuthorship W3106348194A5017511355 @default.
- W3106348194 hasAuthorship W3106348194A5020043337 @default.
- W3106348194 hasAuthorship W3106348194A5045452931 @default.
- W3106348194 hasAuthorship W3106348194A5049704567 @default.
- W3106348194 hasAuthorship W3106348194A5081809233 @default.
- W3106348194 hasAuthorship W3106348194A5087610563 @default.
- W3106348194 hasAuthorship W3106348194A5089946954 @default.
- W3106348194 hasConcept C126322002 @default.
- W3106348194 hasConcept C127413603 @default.
- W3106348194 hasConcept C164705383 @default.
- W3106348194 hasConcept C187320778 @default.
- W3106348194 hasConcept C207103383 @default.
- W3106348194 hasConcept C2776301958 @default.
- W3106348194 hasConcept C2778661090 @default.
- W3106348194 hasConcept C2778715236 @default.
- W3106348194 hasConcept C2778810321 @default.
- W3106348194 hasConcept C2779161974 @default.
- W3106348194 hasConcept C2779668873 @default.
- W3106348194 hasConcept C2780638905 @default.
- W3106348194 hasConcept C2780645631 @default.
- W3106348194 hasConcept C2781009140 @default.
- W3106348194 hasConcept C42219234 @default.
- W3106348194 hasConcept C44249647 @default.
- W3106348194 hasConcept C50382708 @default.
- W3106348194 hasConcept C71924100 @default.
- W3106348194 hasConcept C78519656 @default.
- W3106348194 hasConceptScore W3106348194C126322002 @default.
- W3106348194 hasConceptScore W3106348194C127413603 @default.
- W3106348194 hasConceptScore W3106348194C164705383 @default.
- W3106348194 hasConceptScore W3106348194C187320778 @default.
- W3106348194 hasConceptScore W3106348194C207103383 @default.
- W3106348194 hasConceptScore W3106348194C2776301958 @default.
- W3106348194 hasConceptScore W3106348194C2778661090 @default.
- W3106348194 hasConceptScore W3106348194C2778715236 @default.
- W3106348194 hasConceptScore W3106348194C2778810321 @default.
- W3106348194 hasConceptScore W3106348194C2779161974 @default.
- W3106348194 hasConceptScore W3106348194C2779668873 @default.
- W3106348194 hasConceptScore W3106348194C2780638905 @default.
- W3106348194 hasConceptScore W3106348194C2780645631 @default.
- W3106348194 hasConceptScore W3106348194C2781009140 @default.
- W3106348194 hasConceptScore W3106348194C42219234 @default.
- W3106348194 hasConceptScore W3106348194C44249647 @default.
- W3106348194 hasConceptScore W3106348194C50382708 @default.
- W3106348194 hasConceptScore W3106348194C71924100 @default.
- W3106348194 hasConceptScore W3106348194C78519656 @default.
- W3106348194 hasIssue "Suppl_3" @default.
- W3106348194 hasLocation W31063481941 @default.
- W3106348194 hasOpenAccess W3106348194 @default.
- W3106348194 hasPrimaryLocation W31063481941 @default.
- W3106348194 hasRelatedWork W1993190469 @default.
- W3106348194 hasRelatedWork W2016226059 @default.
- W3106348194 hasRelatedWork W2049310472 @default.
- W3106348194 hasRelatedWork W2321904733 @default.
- W3106348194 hasRelatedWork W2750836949 @default.
- W3106348194 hasRelatedWork W2789710191 @default.
- W3106348194 hasRelatedWork W2800941304 @default.
- W3106348194 hasRelatedWork W2918358868 @default.
- W3106348194 hasRelatedWork W2990629389 @default.
- W3106348194 hasRelatedWork W4228999874 @default.
- W3106348194 hasVolume "142" @default.
- W3106348194 isParatext "false" @default.
- W3106348194 isRetracted "false" @default.
- W3106348194 magId "3106348194" @default.
- W3106348194 workType "article" @default.